Re: Wells et al.: Aflibercept, Bevacizumab, or Ranibizumab...

Re: Wells et al.: Aflibercept, Bevacizumab, or Ranibizumab for diabetic macular edema: Two-year results from a comparative effectiveness randomized clinical trial (Ophthalmology 2016;123:1351-1358)

Tornambe, Paul
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
124
Language:
english
Journal:
Ophthalmology
DOI:
10.1016/j.ophtha.2016.06.064
Date:
March, 2017
File:
PDF, 209 KB
english, 2017
Conversion to is in progress
Conversion to is failed